Determination of melatonin in pharmaceutical formulations and human plasmaby gas chromatography-electron impact mass spectrometry

Citation
A. Covaci et al., Determination of melatonin in pharmaceutical formulations and human plasmaby gas chromatography-electron impact mass spectrometry, BIOMED CHRO, 13(6), 1999, pp. 431-436
Citations number
13
Categorie Soggetti
Chemistry & Analysis
Journal title
BIOMEDICAL CHROMATOGRAPHY
ISSN journal
02693879 → ACNP
Volume
13
Issue
6
Year of publication
1999
Pages
431 - 436
Database
ISI
SICI code
0269-3879(199910)13:6<431:DOMIPF>2.0.ZU;2-R
Abstract
A simple and reliable method for gas chromatography-mass spectrometry (GC-M S) has been developed for the determination of melatonin in commercially av ailable tablet formulations and human plasma. The dissolution of the tablet s in ethyl acetate was simply obtained by sonication. The filtrate of the r esultant solution, after concentration, was derivatized with pentafluoropro pionic anhydride (PFPA) and analysed by GC-MS using splitless injection. Th e linear response range for melatonin was 5-250 ng on column. The same meth od can be used, with minor modifications, for the determination of melatoni n in spiked human plasma in the range 50-1000 pg/mL plasma. Copyright (C) 1 999 John Wiley & Sons, Ltd.